This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss opportunities and challenges involved in therapeutic development.
Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics such as antibody drug conjugates, bispecific antibodies and overcoming the blood-brain barrier. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment.
2014 Sessions for the Conference:
I. Novel Antibody Targets
II. Antibody Selection Methods & Strategies
III. Bispecific Antibodies & Fusion Proteins
IV. Immunomodulatory Biotherapy for Cancer
V. Next Generation of Protein Engineering
VI. Combining Antibody Therapeutics